110 related articles for article (PubMed ID: 23647064)
1. Features and outcomes of diffuse large B-cell lymphoma of the thyroid in a large contemporary cohort.
Costa LJ; Xavier AC
Leuk Lymphoma; 2014 Feb; 55(2):283-7. PubMed ID: 23647064
[TBL] [Abstract][Full Text] [Related]
2. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
Castillo JJ; Winer ES; Olszewski AJ
Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
[TBL] [Abstract][Full Text] [Related]
3. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
[TBL] [Abstract][Full Text] [Related]
4. Multi-Database Description of Primary Splenic Diffuse Large B-Cell Lymphoma.
Byrd KP; Vontela NR; McCullar B; Martin MG
Anticancer Res; 2017 Dec; 37(12):6839-6843. PubMed ID: 29187463
[TBL] [Abstract][Full Text] [Related]
5. Characterizing Autoimmune Disease-associated Diffuse Large B-cell Lymphoma in a SEER-Medicare Cohort.
Koff JL; Rai A; Flowers CR
Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):e115-e121. PubMed ID: 29273217
[TBL] [Abstract][Full Text] [Related]
6. Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma.
Williams JN; Rai A; Lipscomb J; Koff JL; Nastoupil LJ; Flowers CR
Cancer; 2015 Jun; 121(11):1800-8. PubMed ID: 25675909
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
[TBL] [Abstract][Full Text] [Related]
8. A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry.
Gang AO; Pedersen M; d'Amore F; Pedersen LM; Jensen BA; Jensen P; Møller MB; Mourits-Andersen HT; Pedersen RS; Klausen TW; de N Brown P
Leuk Lymphoma; 2015; 56(9):2556-62. PubMed ID: 25629994
[TBL] [Abstract][Full Text] [Related]
9. Unstaged Diffuse Large B-Cell Lymphoma in the United States: Predictors and Patient Outcomes.
Bista A; Sharma S; Rijwani T; Shah BK
Anticancer Res; 2017 Apr; 37(4):1935-1939. PubMed ID: 28373463
[TBL] [Abstract][Full Text] [Related]
10. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
Gundrum JD; Mathiason MA; Moore DB; Go RS
J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
[TBL] [Abstract][Full Text] [Related]
11. Primary Urinary Tract Lymphoma: Rare but Aggressive.
Lontos K; Tsagianni A; Msaouel P; Appleman LJ; Nasioudis D
Anticancer Res; 2017 Dec; 37(12):6989-6995. PubMed ID: 29187485
[TBL] [Abstract][Full Text] [Related]
12. Addition of Rituximab to Chemotherapy Reduced the Rate of Surgery for Gastric-DLBCL Without Increasing Early Mortality.
Prouet P; Giri S; Wiedower E; Fintel A; Yaghmour G; Lamb EP; Deneve J; Fleming M; Dickson P; Chandler JC; Martin MG
Anticancer Res; 2017 Feb; 37(2):813-817. PubMed ID: 28179335
[TBL] [Abstract][Full Text] [Related]
13. Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma.
Olszewski AJ; Winer ES; Castillo JJ
Leuk Res; 2014 Aug; 38(8):866-73. PubMed ID: 24837081
[TBL] [Abstract][Full Text] [Related]
14. Improved Survival With Radiation Therapy in Stage I-II Primary Mediastinal B Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis.
Jackson MW; Rusthoven CG; Jones BL; Kamdar M; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):126-132. PubMed ID: 26547384
[TBL] [Abstract][Full Text] [Related]
15. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
[TBL] [Abstract][Full Text] [Related]
16. A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma, not otherwise specified treated with chemoimmunotherapy.
Hwang HS; Yoon DH; Suh C; Huh J
Ann Hematol; 2016 Aug; 95(8):1249-58. PubMed ID: 27167532
[TBL] [Abstract][Full Text] [Related]
17. Role of radiation therapy in primary tonsil large B cell lymphoma: a SEER-based analysis.
Jia J; Chen W
Radiat Oncol; 2021 Oct; 16(1):193. PubMed ID: 34600539
[TBL] [Abstract][Full Text] [Related]
18. Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database.
Rajyaguru DJ; Bhaskar C; Borgert AJ; Smith A; Parsons B
Leuk Lymphoma; 2017 Sep; 58(9):1-9. PubMed ID: 28278725
[TBL] [Abstract][Full Text] [Related]
19. Thyroid lymphoma. The case for combined modality therapy.
Doria R; Jekel JF; Cooper DL
Cancer; 1994 Jan; 73(1):200-6. PubMed ID: 8275426
[TBL] [Abstract][Full Text] [Related]
20. Treatment Selection and Survival Outcomes in Early-Stage Diffuse Large B-Cell Lymphoma: Do We Still Need Consolidative Radiotherapy?
Vargo JA; Gill BS; Balasubramani GK; Beriwal S
J Clin Oncol; 2015 Nov; 33(32):3710-7. PubMed ID: 26261253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]